efficacy and safety of Biretrix Tri-Active Spray with Doxycycline in patients with mild to moderate truncal acne

Phase 4

Completed

• Conditions: truncal acne; Biretrix tri active spray; sebum; pigment; quality of life

• Registration Number: TCTR20240528001
• Lead Sponsor: Skinova company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2024-05-07
• Study Start: 2024-05-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

1.individuals aging 18-45 years old
2.mild to moderate truncal acne (assessed with PGA)
3. not allergic to Biretrix tri active spray or its compositions

Exclusion Criteria

1. syndromic acne
2.on oral contraceptive pills or medications that affect acne condition
3.have other active skin conditions
4. pregnancy or lactation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
acne count at 3 months after intervention lesion count,tolerability 3 moths after intervention questionnaire

Secondary Outcome Measures

Name	Time	Method
ratio of patient achieving clear/almost clear of acne lesion 3 months lesion count,sebum reduction 3 months sebumeter ,pigment reduction 3 months colorimeter, antera,quality of life and satisfaction 3 months DLQI, patient satisfaction scale